Sonrotoclax
Sonrotoclax is a potent, orally active inhibitor of Bcl2, demonstrating effective cell-killing activity against a range of lymphoma and leukemia cell lines .
Product Specifications
CAS Number
2383086-06-2
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
890.1
Molecular Formula
C49H59N7O7S
Notes
Research use only, not for human use.
Receptor
BCL
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
GTR15077445 1 Vial
Lentiviral human SPEG shRNA (UAS) - Lentiviral human SPEG shRNA (UAS, GFP) (100)
Ask
View Details MBS6235804-01 0.1 mL
Tumor Necrosis Factor (TNF, TNF-alpha, TNFA, TNF-a, Cachectin, DIF, Tumor Necrosis Factor Ligand Superfamily Member 2, TNFSF2) (MaxLight 750)
Ask
View Details